Evidence supports NSAIDs in axSpA

The use of NSAIDs as a first line treatment for axial spondyloarthritis is supported in a recent Cochrane review. The review of 39 studies including 4356 people found high quality evidence that both traditional and COX-2 NSAIDs were more efficacious than placebo in people with axSpA.  The review  by the musculoskeletal group found moderate quality evidence that harms in ...

Already a member?

Login to keep reading.

© 2021 the limbic